Announcements Trials
Browse Landscape

Status

Withdrawn 1Terminated 1Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 24Breast Neoplasms 11Prostatic Neoplasms 10Colorectal Neoplasms 10Hematologic Neoplasms 7Ovarian Neoplasms 6Lung Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Multiple Myeloma 4Advanced Cancer 4Uterine Cervical Neoplasms 3Rectal Neoplasms 3Lymphoma 3Head and Neck Neoplasms 3Gastrointestinal Neoplasms 3Sarcoma 2Peritoneal Neoplasms 2Pain 2Neoplasm Metastasis 2Mouth Neoplasms 2Melanoma 2Low Anterior Resection Syndrome 2Hematopoietic and Lymphoid System Neoplasm 2Fatigue 2Endometrial Neoplasms 2Depression 2Colorectal Neoplasms, Hereditary Nonpolyposis 2Colonic Neoplasms 2Brain Neoplasms 2Bone Neoplasms 2

Interventions

Gemcitabine 358Fluorouracil 94Oxaliplatin 81Capecitabine 74130-nm albumin-bound paclitaxel 71Albumin-Bound Paclitaxel 70Radiotherapy 67Leucovorin 58Irinotecan 49Erlotinib Hydrochloride 47Cisplatin 44Bevacizumab 31pembrolizumab 30Radiosurgery 30Docetaxel 26Taxes 24Nivolumab 24Cetuximab 24Pancreaticoduodenectomy 20Drug Therapy 17folfirinox 16Cyclophosphamide 16Radiation 15Ipilimumab 13Endoscopic Ultrasound-Guided Fine Needle Aspiration 13Surgical Procedures, Operative 12Sorafenib 12Paclitaxel 12Neoadjuvant Therapy 12irinotecan sucrosofate 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Pancreatic Neoplasms × Interviews as Topic × Clear all
NCT04257955 2023-10-31

COMMUNICARE

IRCCS San Raffaele

Completed
32 enrolled
Gastrointestinal

Disease, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡